COVID-19

Study links COVID-19 pandemic to accelerated brain ageing

New research from the University of Nottingham shows the COVID-19 pandemic may have accelerated brain ageing by over five months, even in people who were never infected, due to stress and lifestyle changes.

People with severe mental disorders more likely to die from COVID-19

A new study from Umeå University and Karolinska Institutet has found that people with severe mental disorders have a significantly increased risk of dying from COVID-19.

Over 10 million people receive COVID-19 vaccine

UK reaches significant milestone as more than 10 million people receive the first dose of the COVID-19 vaccine.

Clinical trial looks into mixing different COVID-19 vaccines

A world-first clinical trial looking into mixing different COVID-19 vaccine doses has been backed by £7 million of government funding.

Orthodox Jew’s have one of the highest COVID-19 infection rates

A new study has found that the UK strictly-Orthodox Jewish community experience one of the highest infection rates of COVID-19 throughout 2020.

Coronavirus-related business interruption insurance claims

Jade Brooks, an associate solicitor at Blaser Mills Law, responds to The Supreme Court’s ruling on coronavirus-related business interruption insurance claims and discusses what it means for policyholders.

How to handle vaccine hesitancy at work

Alan Price, CEO at BrightHR, discusses how employers and HR departments can handle vaccine hesitancy in the workplace.

High infection numbers can undo our vaccination programmes

The vaccine roll out gives hope of a return to some form of normality, but current high COVID-19 infection numbers put the success of vaccination programmes at risk. Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences explain why.

South African COVID-19 variant found in UK

Additional testing has been deployed across the UK after a COVID-19 variant originally identified in South Africa has been found .

UK purchases additional 40 million doses of Valneva vaccine

The UK government has announced that it has secured early access to a further 40 million doses of the Valneva COVID-19 vaccine.

Third of Americans say they are unlikely to get COVID-19 vaccine

A new study by the University of California, Davis has found that a third of Americans are either unlikely or hesitant to get a COVID-19 vaccine when it becomes available.

AI technology can help tackle the cancer care backlog

Hugh Bettesworth, CEO, Mirada Medical, explores how AI autocontouring technology can help tackle the cancer care backlog as a result of the COVID-19 pandemic.

Engineers design model for using one ventilator on two patients

Engineers at the University of Bath have published a mathematical model that could help clinicians to safely ventilate two COVID patients on one ventilator.

1 in 3 adults are anxious about COVID-19

Researchers at Duke-NUS Medical School have reported that one in three adults are experiencing psychological distress related to COVID-19, including anxiety and depression.

COVID-19 mortality rates 13 times higher in pregnant women

According to a new study examining the effects of coronavirus in pregnant women, COVID-19 mortality rates showed to be 13 times higher in pregnant mothers.

Antibiotics provide no benefit to COVID-19 patients

The PRINCIPLE trial has found that azithromycin and doxycycline do not provide any recovery benefits for COVID-19 patients.

People with high omega-3 blood levels are less likely to die from COVID-19

Researchers have found that people with higher omega-3 blood levels have a reduced risk of death from COVID-19.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders